166 related articles for article (PubMed ID: 8059833)
1. Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin.
Tan SL; Maconochie N; Doyle P; Campbell S; Balen A; Bekir J; Brinsden P; Edwards RG; Jacobs HS
Am J Obstet Gynecol; 1994 Aug; 171(2):513-20. PubMed ID: 8059833
[TBL] [Abstract][Full Text] [Related]
2. A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization.
MacLachlan V; Besanko M; O'Shea F; Wade H; Wood C; Trounson A; Healy DL
N Engl J Med; 1989 May; 320(19):1233-7. PubMed ID: 2496310
[TBL] [Abstract][Full Text] [Related]
3. Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin.
Balen AH; Tan SL; MacDougall J; Jacobs HS
Hum Reprod; 1993 Jun; 8(6):959-64. PubMed ID: 8345091
[TBL] [Abstract][Full Text] [Related]
4. Low dose clomiphene citrate as a mild stimulation protocol in women with unsuspected poor in vitro fertilization result can generate more oocytes with optimal cumulative pregnancy rate.
Ochin H; Ma X; Wang L; Li X; Song J; Meng Y; Shen J; Cui YG; Liu J
J Ovarian Res; 2018 May; 11(1):37. PubMed ID: 29728130
[TBL] [Abstract][Full Text] [Related]
5. Short-term utilization of a gonadotropin-releasing hormone agonist (buserelin) for induction of ovulation in an in vitro fertilization program.
Loumaye E; de Cooman S; Anoma M; Psalti I; Depreester S; Schmit M; Thomas K
Ann N Y Acad Sci; 1988; 541():96-102. PubMed ID: 3143299
[TBL] [Abstract][Full Text] [Related]
6. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates.
Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
Fertil Steril; 1998 Dec; 70(6):1063-9. PubMed ID: 9848296
[TBL] [Abstract][Full Text] [Related]
7. Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormone.
Rutherford AJ; Subak-Sharpe RJ; Dawson KJ; Margara RA; Franks S; Winston RM
Br Med J (Clin Res Ed); 1988 Jun; 296(6639):1765-8. PubMed ID: 3136830
[TBL] [Abstract][Full Text] [Related]
8. The use of a short regimen of buserelin, a gonadotrophin-releasing hormone agonist, and human menopausal gonadotrophin in assisted conception cycles.
Owen EJ; Davies MC; Kingsland CR; Jacobs HS; Mason BA
Hum Reprod; 1989 Oct; 4(7):749-53. PubMed ID: 2514192
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of long-term unexplained infertility with gonadotropin-releasing hormone agonist analogue and human menopausal gonadotropin.
Aboulghar MA; Mansour RT; Serour GI
Acta Obstet Gynecol Scand; 1990; 69(4):313-5. PubMed ID: 2123068
[TBL] [Abstract][Full Text] [Related]
10. Short-term luteinizing hormone-releasing hormone agonist treatment: prospective trial of a novel ovarian stimulation regimen for in vitro fertilization.
Macnamee MC; Howles CM; Edwards RG; Taylor PJ; Elder KT
Fertil Steril; 1989 Aug; 52(2):264-9. PubMed ID: 2502441
[TBL] [Abstract][Full Text] [Related]
11. Comparative trial of luteinizing hormone-releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in an assisted conception program.
Abdalla HI; Ahuja KK; Leonard T; Morris NN; Honour JW; Jacobs HS
Fertil Steril; 1990 Mar; 53(3):473-8. PubMed ID: 2106453
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of short and ultrashort regimens of gonadotropin-releasing hormone agonist in an in vitro fertilization program.
Acharya U; Irvine S; Hamilton M; Templeton A
Fertil Steril; 1992 Dec; 58(6):1169-73. PubMed ID: 1459268
[TBL] [Abstract][Full Text] [Related]
13. Ovarian hyperstimulation for in vitro fertilization preceded by prolonged administration of a gonadotropin-releasing hormone agonist.
Tanbo T; Dale PO; Abyholm T
Acta Obstet Gynecol Scand; 1990; 69(4):333-7. PubMed ID: 2123069
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of different ovarian stimulation protocols for in vitro fertilization.
Pados G; Tarlatzis BC; Bontis J; Lagos S; Papadimas J; Spanos E; Mantalenakis S
Gynecol Endocrinol; 1995 Jun; 9(2):103-12. PubMed ID: 7502685
[TBL] [Abstract][Full Text] [Related]
15. [Use of an GnRH analogue for induction of gonadotrophin ovulatory surge in cycles stimulated with clomiphene citrate and menopausal gonadotropin in an in vitro fertilization program].
Wołczyński S; Kulikowski M; Syrewicz M; Kuczyński W; Grochowski D; Sola E; Szamatowicz M
Ginekol Pol; 1994 Oct; 65(10):573-7. PubMed ID: 7729718
[TBL] [Abstract][Full Text] [Related]
16. Anti-Müllerian hormone is correlated with cumulative live birth in minimal ovarian stimulation with clomiphene citrate: a retrospective cohort study.
Ezoe K; Ni X; Kobayashi T; Kato K
BMC Pregnancy Childbirth; 2020 Nov; 20(1):740. PubMed ID: 33246461
[TBL] [Abstract][Full Text] [Related]
17. In vitro fertilization with low-dose clomiphene citrate stimulation in women who respond poorly to superovulation.
Awonuga AO; Nabi A
J Assist Reprod Genet; 1997 Oct; 14(9):503-7. PubMed ID: 9401867
[TBL] [Abstract][Full Text] [Related]
18. Inclusion of standard and low-dose gonadotropin releasing hormone-analog (short protocol) in controlled ovarian hyperstimulation regimens in normogonadotropic patients aged 40-48 years who are undergoing in vitro fertilization.
Avrech OM; Orvieto R; Pinkas H; Sapir-Rufas O; Feldberg D; Fisch B
Gynecol Endocrinol; 2004 Nov; 19(5):247-52. PubMed ID: 15726912
[TBL] [Abstract][Full Text] [Related]
19. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
20. Administration of pure follicle-stimulating hormone during gonadotropin-releasing hormone agonist therapy in patients with clomiphene-resistant polycystic ovarian disease: hormonal evaluations and clinical perspectives.
Remorgida V; Venturini PL; Anserini P; Lanera P; De Cecco L
Am J Obstet Gynecol; 1989 Jan; 160(1):108-13. PubMed ID: 2492145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
